28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This
study will evaluate the effect of 28-day repeat dosing of this combination with varying BID
doses of testosterone (T), in combination with a fixed BID dose of dutasteride (D), as well
as a testosterone alone arm, on T and D levels in the blood. The rationale is to look for the
effects of each compound on the other, and to look for any safety problems that may result
when the 2 drugs are given together.